Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients-Reference-Cited by-同舟云学术

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients

Published:2016-08-05 Issue:2 Volume:1 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Condamine Thomas¹,Dominguez George A.¹,Youn Je-In¹,Kossenkov Andrew V.¹,Mony Sridevi¹,Alicea-Torres Kevin¹,Tcyganov Evgenii¹,Hashimoto Ayumi¹,Nefedova Yulia¹,Lin Cindy¹,Partlova Simona¹,Garfall Alfred²³,Vogl Dan T.²³,Xu Xiaowei²,Knight Stella C.⁴,Malietzis George⁴⁵,Lee Gui Han⁴⁵,Eruslanov Evgeniy²,Albelda Steven M.²³,Wang Xianwei⁶,Mehta Jawahar L.⁶,Bewtra Meenakshi³,Rustgi Anil²³,Hockstein Neil⁷,Witt Robert⁷,Masters Gregory⁷,Nam Brian⁷,Smirnov Denis⁸,Sepulveda Manuel A.⁸,Gabrilovich Dmitry I.¹

Affiliation:

1. Wistar Institute, Philadelphia, PA 19104, USA.

2. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

3. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

4. Antigen Presentation Research Group, Imperial College London, London HA1 3UJ, UK.

5. St. Mark’s Hospital, Harrow HA1 3UJ, UK.

6. Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

7. Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE 19713, USA.

8. Janssen Oncology Therapeutic Area, Janssen Research and Development LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA 19477, USA.

Abstract

PMN-MDSC in cancer patients can be distinguished from neutrophils by a genomic signature and by expression of the LOX-1 receptor.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference52 articles.

1. Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells

2. Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy

3. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

4. CD14+S100A9+Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung Cancer

5. A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Cited by 546 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deterministic reprogramming of neutrophils within tumors;Science;2024-01-12

2. Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit;Cancers;2024-01-11

3. Myeloid-derived suppressor cells in cancer and cancer therapy;Nature Reviews Clinical Oncology;2024-01-08

4. OMIP‐100: A flow cytometry panel to investigate human neutrophil subsets;Cytometry Part A;2024-01-05

5. Immature neutrophils and myeloid-derived suppressor cells in sepsis: differences in occurrence kinetics;Critical Care;2024-01-02